The trail making test in prodromal huntington disease: Contributions of disease progression to test performance

Journal of Clinical and Experimental Neuropsychology

Volumn 33, Issue 5, 2011, Pages 567-579

  O'Rourke, Justin J F ^a,b   Beglinger, Leigh J ^a   Smith, Megan M ^a   Mills, James ^a   Moser, David J ^a   Rowe, Kelly C ^a,b   Langbehn, Douglas R ^a   Duff, Kevin ^a   Stout, Julie C ^c   Harrington, Deborah L ^d   Carlozzi, Noelle ^e   Paulsen, Jane S ^a,b,f  

^a UNIVERSITY OF IOWA   (United States)

^b UNIVERSITY OF IOWA   (United States)

^c MONASH UNIVERSITY   (Australia)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e KESSLER FOUNDATION   (United States)

^f E11 SSH   (United States)

Author keywords

Cognition; Huntington disease; Motor; Neurodegenerative; Psychiatric

Indexed keywords

ADOLESCENT; ADULT; AGED; ANALYSIS OF VARIANCE; ARTICLE; ASSOCIATION; COGNITIVE DEFECT; DISABILITY; DISEASE COURSE; FEMALE; HUMAN; HUNTINGTON CHOREA; MALE; MIDDLE AGED; PREDICTIVE VALUE; PSYCHOLOGIC TEST; PSYCHOLOGICAL RATING SCALE; REGRESSION ANALYSIS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; ASSOCIATION; COGNITION DISORDERS; DISABILITY EVALUATION; DISEASE PROGRESSION; FEMALE; HUMANS; HUNTINGTON DISEASE; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PSYCHIATRIC STATUS RATING SCALES; REGRESSION ANALYSIS; TRAIL MAKING TEST; YOUNG ADULT;

EID: 79958170933     PISSN: 13803395     EISSN: 1744411X     Source Type: Journal    
DOI: 10.1080/13803395.2010.541228     Document Type: Article

References (57)

1. Austin, M. P., Mitchell, P., Wilhelm, K., Parker, G., Hickie, I., Brodaty, H., et al. (1999). Cognitive function in depression: A distinct pattern of frontal impairment in melancholia? Psychological Medicine, 29(1), 73-85. (Pubitemid 29034524)
2. Aylward, E. H., Sparks, B. F., Field, K. M., Yallapragada, V., Shpritz, B. D., Rosenblatt, A., et al. (2004). Onset and rate of striatal atrophy in preclinical Huntington disease. Neurology, 63(1), 66-72. (Pubitemid 38943780)
3. Beck, A. T., Steer, R. A., & Brown, G. K. (1996). Manual for Beck Depression Inventory II. San Antonio, TX: The Psychological Corporation.
4. Bigal, M., Rapoport, A., Sheftell, F., Tepper, D., & Tepper, S. (2008). Memantine in the preventive treatment of refractory migraine. Headache, 48(9), 1337-1342.
5. Biglan, K. M., Ross, C. A., Langbehn, D. R., Aylward, E. H., Stout, J. C., Queller, S., et al. (2009). Motor abnormalities in premanifest persons with Huntington's disease: The PREDICT-HD study. Movement Disorders, 24(12), 1763-1772.
6. Brandt, J., Shpritz, B., Codori, A. M., Margolis, R., & Rosenblatt, A. (2002). Neuropsychological manifestations of the genetic mutation for Huntington's disease in presymptomatic individuals. Journal of the International Neuropsychological Society, 8(7), 918-924. (Pubitemid 35355860)
7. Caviness, J. N., Driver-Dunckley, E., Connor, D. J., Sabbagh, M. N., Hentz, J. G., Noble, B., et al. (2007). Defining mild cognitive impairment in Parkinson's disease. Movement Disorders, 22(9), 1272-1277. (Pubitemid 47325034)
8. Chen, P., Ratcliff, G., Belle, S. H., Cauley, J. A., DeKosky, S. T., & Ganguli, M. (2000). Cognitive tests that best discriminate between presymptomatic AD and those who remain nondemented. Neurology, 55(12), 1847-1853. (Pubitemid 32103967)
9. Coffey, C. E., Ratcliff, G., Saxton, J. A., Bryan, R. N., Fried, L. P., & Lucke, J. F. (2001). Cognitive correlates of human brain aging: A quantitative magnetic resonance imaging investigation. Journal of Neuropsychiatry and Clinical Neurosciences, 13(4), 471-485. (Pubitemid 33140920)
10. Crowe, S. F. (1998). The differential contribution of mental tracking, cognitive flexibility, visual search, and motor speed to performance on parts A and B of the Trail Making Test. Journal of Clinical Psychology, 54(5), 585-591. (Pubitemid 28366396)
11. Decruyenaere, M., Evers-Kiebooms, G., Boogaerts, A., Cassiman, J. J., Cloostermans, T., Demyttenaere, K., et al. (1995). Predictive testing for Huntington's disease: Risk perception, reasons for testing and psychological profile of test applicants. Genetic Counseling, 6(1), 1-13.
12. Derogatis, L. R. (1994). SCL-R: Symptom Checklist-90-R: Administration, scoring, and procedures manual (3rd ed.). Minneapolis, MN: National Computer Systems.
13. Dichgans, M., Markus, H. S., Salloway, S., Verkkoniemi, A., Moline, M., Wang, Q., et al. (2008). Donepezil in patients with subcortical vascular cognitive impairment: A randomised double-blind trial in CADASIL. Lancet Neurology, 7(4), 310-318.
14. Drane, D. L., Yuspeh, R. L., Huthwaite, J. S., & Klingler, L. K. (2002). Demographic characteristics and normative observations for derived-trail making test indices. Neuropsychiatry, Neuropsychology, and Behavioral Neurology, 15(1), 39-43. (Pubitemid 34213815)
15. Duff, K., Paulsen, J. S., Beglinger, L. J., Langbehn, D. R., & Stout, J. C. (2007). Psychiatric symptoms in Huntington's disease before diagnosis: The Predict-HD study. Biological Psychiatry, 62(12), 1341-1346. (Pubitemid 350180721)
16. Fagerlund, B., Soholm, B., Fink-Jensen, A., Lublin, H., & Glenthoj, B. Y. (2007). Effects of donepezil adjunctive treatment to ziprasidone on cognitive deficits in schizophrenia: A double-blind, placebo-controlled study. Clinical Neuropharmacology, 30(1), 3-12. (Pubitemid 46204312)
17. Foroud, T., Siemers, E., Kleindorfer, D., Bill, D. J., Hodes, M. E., Norton, J. A., et al. (1995). Cognitive scores in carriers of Huntington's disease gene compared to noncarriers. Annals of Neurology, 37(5), 657-664.
18. Gohier, B., Ferracci, L., Surguladze, S. A., Lawrence, E., El Hage, W., Kefi, M. Z., et al. (2009). Cognitive inhibition and working memory in unipolar depression. Journal of Affective Disorders, 116 (1-2), 100-105.
19. Hammar, A., & Ardal, G. (2009). Cognitive functioning in major depression-a summary. Frontiers in Human Neuroscience, 3, 26.
20. Heaton, R. K., Nelson, L. M., Thompson, D. S., Burks, J. S., & Franklin, G. M. (1985). Neuropsychological findings in relapsing-remitting and chronic-progressive multiple sclerosis. Journal of Consulting and Clinical Psychology, 53(1), 103-110. (Pubitemid 15096165)
21. Horton, A. M., & Roberts, C. (2001a). Derived trail making test indices in a sample of substance abusers: Demographic effects. International Journal of Neuroscience, 111 (1-2), 123-132. (Pubitemid 34000220)
22. Horton, A. M., & Roberts, C. (2001b). Sex, ethnicity, age and education effects on the Trail Making test in a sample of cocaine abusers. International Journal of Neuroscience, 108 (3-4), 281-290. (Pubitemid 32679699)
23. Horton, A. M., & Roberts, C. (2003). Demographic effects on the Trail Making Test in a drug abuse treatment sample. Archives of Clinical Neuropsychology, 18(1), 49-56. (Pubitemid 36120393)
24. Hoth, K. F., Paulsen, J. S., Moser, D. J., Tranel, D., Clark, L. A., & Bechara, A. (2007). Patients with Huntington's disease have impaired awareness of cognitive, emotional, and functional abilities. Journal of Clinical and Experimental Neuropsychology, 29(4), 365-376. (Pubitemid 46763628)
25. Huntington Study Group. (1996). Unified Huntington's Disease Rating Scale: Reliability and consistency. Movement Disorders, 11(2), 136-142.
26. Lamberty, G. J., Putnam, S. H., Chatel, D. M., Bieliauskas, L. A., & Adams, K. A. (1994). Derived Trail Making Test indices: A preliminary report. Neuropsychiatry, Neuropsychology, and Behavioral Neurology, 7, 230-234. (Pubitemid 24268946)
27. Langbehn, D. R., Brinkman, R. R., Falush, D., Paulsen, J. S., & Hayden, M. R. (2004). A new model for prediction of the age of onset and penetrance for Huntington's disease based on CAG length. Clinical Genetics, 65(4), 267-277. (Pubitemid 38443548)
28. Langbehn, D. R., Hayden, M. R., & Paulsen, J. S. (2010). CAG-repeat length and the age of onset in Huntington disease (HD): A review and validation study of statistical approaches. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics, 153 B, 397-408.
29. Langbehn, D. R., & Paulsen, J. S. (2007). Predictors of diagnosis in Huntington disease. Neurology, 68(20), 1710-1717. (Pubitemid 46763259)
30. Lange, H. W. (1981). Quantitative changes of telencephalon, diencephalon, and mesencephalon in Huntington's chorea, postencephalitic, and idiopathic parkinsonism. Verhandlungen der Anatomischen Gesellschaft, 75, 923-925.
31. Lange, R. T., Iverson, G. L., Zakrzewski, M. J., Ethel-King, P. E., & Franzen, M. D. (2005). Interpreting the trail making test following traumatic brain injury: Comparison of traditional time scores and derived indices. Journal of Clinical and Experimental Neuropsychology, 27(7), 897-906. (Pubitemid 41374867)
32. Larsson, M. U., Almkvist, O., Luszcz, M. A., & Wahlin, T. B. (2008). Phonemic fluency deficits in asymptomatic gene carriers for Huntington's disease. Neuropsychology, 22(5), 596-605.
33. Mahant, N., McCusker, E. A., Byth, K., & Graham, S. (2003). Huntington's disease: Clinical correlates of disability and progression. Neurology, 61(8), 1085-1092. (Pubitemid 37461942)
34. Misdraji, E. L., & Gass, C. S. (2010). The Trail Making Test and its neurobehavioral components. Journal of Clinical and Experimental Neuropsychology, 32, 159-163.
35. O'Rourke, J. J. F., Beglinger, L. J., Mills, J., Smith, M. M., Stout, J. C., Queller, S., et al. (2009). Characterizing psychomotor declines in prodromal Huntington disease with the Trail Making Test [Abstract]. Neurotherapeutics, 7, 147.
36. Paulsen, J. S. (1999). Understanding behavior in Huntington's disease. New York, NY: Huntington's Disease Society of America.
37. Penney, J. B., Jr., Young, A. B., Shoulson, I., Starosta-Rubenstein, S., Snodgrass, S. R., Sanchez-Ramos, J., et al. (1990). Huntington's disease in Venezuela: 7 years of follow-up on symptomatic and asymptomatic individuals. Movement Disorders, 5(2), 93-99. (Pubitemid 20166182)
38. Porter, R. J., Gallagher, P., Thompson, J. M., & Young, A. H. (2003). Neurocognitive impairment in drug-free patients with major depressive disorder. British Journal of Psychiatry, 182, 214-220. (Pubitemid 36286734)
39. Reitan, R. M. (1958). Validity of the trail making test as an indicator of organic brain damage. Perceptual and Motor Skills, 8, 271-276.
40. Reitan, R. M., & Wolfson, D. (1985). The Halstead-Reitan Neuropsychological Test Battery: Therapy and clinical interpretation. Tucson, AZ: Neuropsychological Press.
41. Rios, M., Perianez, J. A., & Munoz-Cespedes, J. M. (2004). Attentional control and slowness of information processing after severe traumatic brain injury. Brain Injury, 18(3), 257-272. (Pubitemid 38213176)
42. Rosas, H. D., Salat, D. H., Lee, S. Y., Zaleta, A. K., Pappu, V., Fischl, B., et al. (2008). Cerebral cortex and the clinical expression of Huntington's disease: Complexity and heterogeneity. Brain, 131(4), 1057-1068. (Pubitemid 351499426)
43. Rosas, H. D., Tuch, D. S., Hevelone, N. D., Zaleta, A. K., Vangel, M., Hersch, S. M., et al. (2006). Diffusion tensor imaging in presymptomatic and early Huntington's disease: Selective white matter pathology and its relationship to clinical measures. Movement Disorders, 21(9), 1317-1325. (Pubitemid 44613279)
44. Sanchez-Cubillo, I., Perianez, J. A., Adrover-Roig, D., Rodriguez-Sanchez, J. M., Rios-Lago, M., Tirapu, J., et al. (2009). Construct validity of the Trail Making Test: Role of task-switching, working memory, inhibition/interference control, and visuomotor abilities. Journal of the International Neuropsychological Society, 15(3), 438-450.
45. Saxton, J., Ratcliff, G., Newman, A., Belle, S., Fried, L., Yee, J., et al. (2000). Cognitive test performance and presence of subclinical cardiovascular disease in the cardiovascular health study. Neuroepidemiology, 19(6), 312-319.
46. Schear, J. M., & Sato, S. D. (1989). Effects of visual acuity and visual motor speed and dexterity on cognitive test performance. Archives of Clinical Neuropsychology, 4(1), 25-32. (Pubitemid 19063037)
47. Smith, A. (1991). Symbol Digit Modalities Test. Los Angeles, CA: Western Psychological Services.
48. Spikman, J. M., Kiers, H. A., Deelman, B. G., & van Zomeren, A. H. (2001). Construct validity of concepts of attention in healthy controls and patients with CHI. Brain and Cognition, 47(3), 446-460. (Pubitemid 34001603)
49. Stroop, J. R. (1935). Studies of interference in serial verbal reactions. Journal of Experimental Psychology, 18, 643-662.
50. Stuss, D. T., Bisschop, S. M., Alexander, M. P., Levine, B., Katz, D., & Izukawa, D. (2001). The Trail Making Test: A study in focal lesion patients. Psychological Assessment, 13(2), 230-239. (Pubitemid 32552945)
51. Tekin, S., & Cummings, J. L. (2002). Frontal-subcortical neuronal circuits and clinical neuropsychiatry: An update. Journal of Psychosomatic Research, 53, 647-654. (Pubitemid 36292444)
52. Tombaugh, T. N. (2004). Trail Making Test A and B: Normative data stratified by age and education. Archives of Clinical Neuropsychology, 19(2), 203-214. (Pubitemid 38316871)
53. Tremont, G., Hoffman, R. G., Scott, J. G., & Adams, R. L. (1998). Effect of intellectual level on neuropsychological test performance: A response to Dodrill (1997). Clinical Neuropsychologist, 12(4), 560-567. (Pubitemid 29267978)
54. Verny, C., Allain, P., Prudean, A., Malinge, M., Gohier, B., Scherer, C., et al. (2007). Cognitive changes in asymptomatic carriers of the Huntington disease mutation gene. European Journal of Neurology, 14(12), 1344-1350. (Pubitemid 350135299)
55. Walker, F. O. (2007). Huntington's disease. Lancet, 369(9557), 218-228. (Pubitemid 46107685)
56. Wechsler, D. (1997). WAIS-III administration and scoring manual. San Antonio, TX: The Psychological Corporation.
57. Yaffe, K., Blackwell, T., Gore, R., Sands, L., Reus, V., & Browner, W. S. (1999). Depressive symptoms and cognitive decline in nondemented elderly women: A prospective study. Archives of General Psychiatry, 56(5), 425-430. (Pubitemid 29215431)